Schott Pharma throws down €100M to build new sterile cartridge facility at Hungary manufacturing site
Schott Pharma—which makes glass vials, syringes, delivery devices and other key packaging products for the pharmaceutical industry—is investing more than 100 million euros ($115 million) at its manufacturing site in Lukácsháza, Hungary, to build a new facility focused on sterile ready-to-use cartridges.
Schott Pharma—which makes glass vials, syringes, delivery devices and other key packaging products for the pharmaceutical industry—is investing more than 100 million euros ($115 million) at its manufacturing site in Lukácsháza, Hungary, to build a new facility focused on sterile ready-to-use cartridges.
